Business

Getting geroprotective drugs to market for specific disease applications is the first step in eventually making them available for healthier aging.

Oregon’s grand experiment in training psychedelic facilitators is facing a tangle of ambiguity and red tape.

“Beanless coffee” is making its way to store shelves, but will consumers give up their beloved cup of Joe for a more eco-friendly option?

Entrepreneurs are brewing up fish, meat, and fowl in spite of skeptics who say that lab-grown meat will never be feasible at an industrial scale.

What to expect in genetic engineering, neuroscience, psychedelics, longevity research, digital health, food, human performance, wellbeing, and of course, ChatGPT.

AI can help overcome both scientific and financial hurdles to tackle this serious threat to global health.

SiPhox’s coming silicon photonics technology seems to deliver on at least some of the promises Theranos made.

The maniacally focused founder of Insilico Medicine is going all in on AI to discover new medicines and extend lifespan.

As organ-on-a-chip technology comes of age, the bipartisan FDA Modernization Act 2.0 would remove the requirement that new drugs must undergo animal testing before human clinical trials.

A new wave of spit-and-swab home testing kits promises to give individuals more control over their own health.